In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Mendor brings in €8.1mm through its Series B round

Executive Summary

Mendor Oy (diabetes care products) has raised €8.1mm ($11.64mm) through its Series B venture round. Finnish entrepreneur Risto Siilasmaa led and was joined by Life Sciences Partners, Finnish Industry Investment, Ilmarinen (a Finnish mutual pension insurance company), Biothom, and returning shareholder Finnvera. LSP will contribute one board member.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Glucose Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register